Sinusitis - chronic and Injection site pain

Summary:

Injection site pain is found among people with Sinusitis - chronic, especially for people who are female, 50-59 old.

The study analyzes which people have Injection site pain with Sinusitis - chronic. It is created by eHealthMe based on reports of 64 people who have Sinusitis - chronic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Sinusitis - chronic?

Sinusitis - chronic is found to be associated with 1,004 drugs and 760 conditions by eHealthMe. Check the latest studies of Sinusitis - chronic.

What is Injection site pain?

Injection site pain is found to be associated with 1,872 drugs and 1,944 conditions by eHealthMe. Check the latest studies of Injection site pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

64 people who have Sinusitis - Chronic and Injection Site Pain are studied.

Would you have Injection site pain when you have Sinusitis - chronic?

Gender of people who have Sinusitis - Chronic and experienced Injection Site Pain *:

female: 77.97 %
male: 22.03 %

Age of people who have Sinusitis - Chronic and experienced Injection Site Pain *:

Common co-existing conditions for these people *:

Nasal Polyps (masses that develop in the lining of the nose): 24 people, 37.50%
Asthma: 5 people, 7.81%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 7.81%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 4 people, 6.25%
Gastric Ulcer (stomach ulcer): 4 people, 6.25%
Upper Respiratory Tract Inflammation: 4 people, 6.25%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 4.69%
Hypersensitivity: 3 people, 4.69%
High Blood Pressure: 2 people, 3.12%
Nasopharyngitis (inflammation of the nasopharynx): 2 people, 3.12%

Common drugs taken by these people *:

Dupixent: 51 people, 79.69%
Prednisone: 6 people, 9.38%
Zyrtec: 5 people, 7.81%
Montelukast Sodium: 5 people, 7.81%
Azelastine Hydrochloride: 5 people, 7.81%
Mobic: 4 people, 6.25%
Vitamin D3: 4 people, 6.25%
Enbrel: 4 people, 6.25%
Halcion: 4 people, 6.25%
Fish Oil: 4 people, 6.25%

Common symptoms for these people *:

Injection Site Swelling: 12 people, 18.75%
Injection Site Erythema (redness at injection site): 11 people, 17.19%
Joint Pain: 9 people, 14.06%
Injection Site Bruising: 8 people, 12.50%
Injection Site Reaction: 7 people, 10.94%
Drug Ineffective: 7 people, 10.94%
Pain In Extremity: 7 people, 10.94%
Abdominal Pain Upper: 6 people, 9.38%
Injection Site Haemorrhage (bleeding from injection site): 6 people, 9.38%
Cough: 6 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Injection site pain?

- Check whether Injection site pain is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Injection site pain and Sinusitis - chronic, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.